Twitch potentiation: a potential source of error during neuromuscular monitoring with acceleromyography in anesthetized dogs

ObjectiveTo measure twitch potentiation (the staircase phenomenon) in anesthetized dogs, and assess its relevance during neuromuscular monitoring with acceleromyography (AMG).Study designRandomized, prospective clinical trial.AnimalsSixteen dogs undergoing ovariohysterectomy.MethodsUnder isoflurane anesthesia, neuromuscular function was monitored with train-of-four (TOF) stimuli every 15 seconds and quantified by AMG. Neuromuscular blockade (NMB) was produced with 0.15 mg kg^?1 atracurium IV. Dogs were randomly divided into two groups; a potentiation group (PG) in which TOF stimulation was applied for 20 minutes before atracurium was administered; and a control group (CG) where no such time was allowed. In both groups, the AMG was calibrated (at tCAL) just before atracurium was administered. TOF stimulation continued throughout the experiment in all dogs. The height of the first twitch (T₁) (expressed as a fraction of T₁ at tCAL) and train-of-four ratio (TOFR) were recorded until TOFR returned to ≥90%.ResultsIn PG, T₁ increased significantly (p = 0.0078) from a median of 102% (range, 95, 109) at baseline to 118% (100, 142) at 20 minutes. In PG, no difference was found between T₁ at tCAL (immediately before atracurium administration) and T₁ when neuromuscular transmission returned (p = 0.42). In the CG, T₁ increased significantly between tCAL and the time neuromuscular transmission returned (p = 0.027). TOFR did not increase during twitch potentiation (all p = 0.32).Conclusions and clinical relevanceT₁ increased significantly during 20 minutes of uninterrupted TOF stimulation in the absence of NMB, establishing that twitch potentiation occurs in anesthetized dogs. With no time for potentiation, T₁ increased during the course of recovery from NMB; this phenomenon introduces a bias in T₁ measurements and could affect studies reporting potency and duration of NMB based on T₁ or single twitches. TOFR was unaltered by potentiation emphasizing its clinical usefulness for excluding post-operative residual NMB.